Skip to main content

Table 1 Baseline demographics

From: Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
Diagnosis MCI MCI MCI MCI MCI AD AD PSP
Age (years) 71 78 68 59 72 63 55 68
Gender Female Male Female Female Male Male Female Male
MMSE 30 29 30 29 29 15 16 29
MoCA 21 24 27 28 24 6 2 23
Global 18F-AZD4694 SUVR 2.19 1.89 1.73 0.96 0.94 2.64 2.24 1.04
  1. AD Alzheimer’s disease, MCI mild cognitive impairment, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, PSP progressive supranuclear palsy, SUVR standardized uptake value ratio